晚期以纤溶为主，有严重出血倾向，方可抗纤溶治疗。
Antiplasmin may be used only for patients with hemorrhagic tendency.
是否治疗的决定应由参与会诊的眼科医生作出，具体措施包括手术减压，纤溶或溶栓药物，全身甾体激素治疗以及血液稀释疗法。
The decision to institute treatment should be left to the consulting ophthalmologist and may include surgical decompression, fibrinolytic or thrombolytic agents, systemic steroids, and hemodilution.
公众应当认识到，只有食品和药物管理局核准的中风治疗药物(组织型纤溶酶原激活剂)必须在症状出现的3小时内给予。
The public should be aware that the only Food and Drug Administration-approved stroke treatment medication must be administered within 3 hours of symptom onset.
结论疏血通注射液具有明显抗凝、促纤溶作用，对急性脑梗死的治疗和预防安全有效。
Conclusion Shuxuetong injection is effective and safe in treatment and prevention of acute cerebral infarction by accelerating fibrinolysis activity and inhibiting coagulation activity.
结论：瘢痕的纤溶系统理论观点新颖，立论充分，有望为瘢痕的康复治疗提供新的参考。
CONCLUSION: the theory of fibrinolysis system is new and persuasible, which may provide new scientific reference for the rehabilitation therapy of pathologic scar.
探讨原发性肝癌介入治疗前后凝血及纤溶功能的变化。
Interventional therapy can improve blood coagulation and fibrinolytic function of patients with primary hepatocellular carcinoma.
纤溶系统活性对ACS的诊断、临床治疗及预后预测的评估有重要价值。
So the activity of fibrinolytic system can provide valuable information in the diagnosis, assessment of clinical therapy and prognostic prediction of ACS.
目的观察应用重组组织型纤溶酶原激活剂溶栓治疗急性心肌梗死的效果。
Objective to observe the effect of recombinant tissue plasminogen activator in the treatment of acute myocardial infarction.
目的评价纤溶酶在治疗结核性胸膜炎胸膜肥厚中的效果。
Objective To evaluation the effect of plasmin in the treatment of Pleural Thickening by Tuberculous Pleurisy.
尿激酶是一种纤溶酶原激活剂，临床上用于治疗血栓。
Urokinase, a human plasminogen activator, is used clinically to promote the dissolution of thrombi.
困此，伤后迅速温浸复温，及时的去纤、溶栓病因治疗是提高疗效的关键环节。
It is suggested that the rapid rewarming, defibrination and lysothrombus after frostbite are play an important role in the increasing effect of treatment on severe frostbite.
目的探讨东菱克栓酶治疗急性脑梗死对凝血与纤溶系统的影响及意义。
Objective To explore the effects of Batroxobin on coagulation and fibrinolytic system in patients with acute cerebral infarction.
目的探讨急性脑梗塞患者用东菱克栓酶治疗对其凝血与纤溶系统的影响。
Objective To explore the effects of Batroxobin on coagulation and fibrinolytic system in the patients with acute cerebral infarction.
目的：观察小剂量长疗程尿纤溶酶原激活物(u - PA)治疗不稳定型心绞痛(uap)的临床疗效。
Objective: to investigate the clinical effectiveness of prolonged low-dose urine plasminogen activator (u-PA) therapy in patients with unstable angina pectoris (UAP).
目的观察纤溶酶治疗下肢深静脉血栓的临床疗效。
Objective To investigate the treatment effect of deep venous thrombosis of lower extremities with fibrinolysin.
目的研究体外治疗性超声(etus)对正常人体凝血及纤溶系统的影响。
ObjectiveTo study the effect and safety of external therapeutic ultrasound (ETUS) on the normal human body blood coagulation and fibrinolytic system.
目的观察急性白血病（AL）患者抗凝纤溶指标的变化以探索其在AL诊断、治疗及预后判断中的意义。
Objective To observe the changes of anticoagulation and fibrinolysis markers in patients with acute leukemia (AL), and explore its significance in diagnosing, treatment and prognosis.
目的观察尿激酶(UK)治疗急性脑梗死的疗效及血浆纤溶酶的活性变化。
Objective To observe the clinical and fibrinolytic effect of Urokinase (UK) therapy in the acute cerebral infarction, and alteration of D-dimer concentrations and plasmin activity.
目的：探讨急性冠脉综合征患者应用阿托伐他汀调脂治疗后对血管内皮舒张功能、血浆纤溶酶原激活物抑制物1及血管内皮素1的影响。
Objective To study the effects of atorvastatin cholesterol-lowering therapy on vascular endothelial function and plasminogen activator inhibitor-1 in acute coronary syndromes.
目的探讨纤溶酶治疗全聋型突发性耳聋的疗效。
To study the efficacy of fibrinogenase in the treatment of sudden hearing loss.
结论纤溶酶治疗全聋型突发性耳聋有效、安全。
Conclusion Fibrinogenase is effective and safe in the treatment of sudden hearing loss.
观察了去纤酶溶栓治疗急性心肌梗塞的效果和副作用。
To investigate the thrombolytic effects of defibrace, 78 patients were on a trial therapy with defibrase against 70 patients on conventional therapy.
摘要：纤溶酶在溶栓治疗中起重要作用，能够溶解血凝块的主要成分纤维蛋白。
Abstract: Fibrinolytic enzyme plays an important role in thrombolytic therapy, and they can dissolve fibrin which is the main components of blood clots.
摘要：纤溶酶在溶栓治疗中起重要作用，能够溶解血凝块的主要成分纤维蛋白。
Abstract: Fibrinolytic enzyme plays an important role in thrombolytic therapy, and they can dissolve fibrin which is the main components of blood clots.
应用推荐